Dr Reddys Laboratories Ltd News
Dr Reddy's sees sharpest intra-day rally since Sept 2020; stock surges 8%_64799
The stock gained 9 per cent in two days after the pharma company reported better-than-expected revenue growth in March quarter (Q4FY22).
 "Dr Reddy's sees sharpest intra-day rally since Sept 2020; stock surges 8%_64799")
Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit_64417
Dr Reddy's Q4 results: The revenue was up 15% to Rs 5,437 crore for the quarter under review
 "Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit_64417")
Dr Reddy's plans new brands in Russia, says no issue with funds in country_64479
The company's Russian revenue was at Rs 686 crore for Q4FY22, a year-on-year growth of 70%.
Dr Reddy's Q4 PAT may rise 28% YoY; margins likely to fall, say analysts_64048
The pharmaceutical giant may witness some impact due to its large exposure of the business to Russia, and CIS regions.
 "Dr Reddy's Q4 PAT may rise 28% YoY; margins likely to fall, say analysts_64048")
75% of Nifty50 stocks trade below 200-DMA; look weak on the charts_60279
Tech Mahindra and Wipro have tumbled over 30 per cent, while Apollo Hospitals Enterprise and Dr. Reddy's Laboratories have plummeted 22 per cent so far in calendar year 2022 (CY22)
 "75% of Nifty50 stocks trade below 200-DMA; look weak on the charts_60279")
Sell-off toll! HDFC twins, HUL, Dr.Reddy's among Nifty50 stks at 52-wk lows_39661
Apart from the 8 stocks among the Nifty50 index, a total of 26 stocks too dropped to their respective 52-week lows among the Nifty500 index.
 "Sell-off toll! HDFC twins, HUL, Dr.Reddy's among Nifty50 stks at 52-wk lows_39661")
Valuations turning attractive for Dr Reddy's as company outperforms sector_38402
US price erosion, India growth trends would be keenly tracked
Dr Reddy's falls 3%, hits 52-week low; stock slips 10% in one month_36391
The stock of the pharmaceutical company, which has a significant presence in the Russian market, has fallen below its previous low of Rs 4,135.90 touched on March 19, 2021
Binnopharm to acquire 2 anti-bacterial brands from Dr Reddy's_35346
During the transition period, Dr Reddy's will continue to supply the product to Binnopharm Group to ensure availability in the market
 "Binnopharm to acquire 2 anti-bacterial brands from Dr Reddy's_35346")
Dr Reddy's Lab Q3 results: Net profit soars over 25 times to Rs 707 cr_24479
Revenues stood at Rs 5,319.7 crore during the third quarter as compared with Rs 4,929.6 crore in the same period of 2020-21
Viral vaccines, vector platforms may become new growth areas: DRL chief_21780
In a Q&A, the chairman of Dr Reddy's Laboratories dwells, among other things, on the draft R&D policy and the first-ever Global Innovation Summit of the pharma sector held last November
 "Viral vaccines, vector platforms may become new growth areas: DRL chief_21780")
Pharma shares trade firm; Laurus up 2%, Sun Pharma nears 52-week high_12610
Sun Pharma, Cipla, Natco, Dr Reddy's, Torrent Pharma, Aurobindo Pharma and Strides have launched a generic version of Molnupiravir in India post approval for emergency use authorisation from DCGI
 "Pharma shares trade firm; Laurus up 2%, Sun Pharma nears 52-week high_12610")
Here's why HDFC Securities is bullish on HCL Tech, Dr Reddy's Labs_9983
Nifty should be held long with the stoploss of 16,650.
 "Here's why HDFC Securities is bullish on HCL Tech, Dr Reddy's Labs_9983")
RIL, HCL Tech: These 7 oversold stocks are set to lead market recovery_9569
The underneath strength, preferably read as price action, has been able to hold ground around the major neckline supports for these stocks
 "RIL, HCL Tech: These 7 oversold stocks are set to lead market recovery_9569")
Dr Reddy's may underperform over concerns about launch of complex products_6569
For rerating, it needs sustained growth in India, recovery in US
BSE Healthcare index up 2%; Cipla, Alkem, Dr.Reddy's rally up to 8%_210
The pharma index had taken a breather over the past three months after displaying relative out-performance during CY20-21.
 "BSE Healthcare index up 2%; Cipla, Alkem, Dr.Reddy's rally up to 8%_210")
